Progress Pulse

Short summaries of scientific findings from across the St. Jude research enterprise.

Study highlights the significance of measurable residual disease in predicting outcomes and guiding treatment in pediatric leukemia

See how measurable residual disease helps predict outcomes for children with leukemia.

Clinical Outcomes of Respiratory Syncytial Virus Infection Among Pediatric Immunocompromised Hosts

Learn how RSV can impact children with cancer.

Targeting oncofetal tenascin C with immunotherapy requires a signal boost

Adding activation signals improves solid and brain tumor immunotherapy.

St. Jude co-led multi-institution collaboration uncovers a predisposition gene for osteosarcoma

St. Jude scientists have discovered a new predisposition gene in a type of pediatric bone cancer.